tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH
90.805USD
+0.275+0.30%
收盘 12/30, 16:00美东报价延迟15分钟
18.00B总市值
22.40市盈率 TTM

Zimmer Biomet Holdings Inc

90.805
+0.275+0.30%

关于 Zimmer Biomet Holdings Inc 公司

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

Zimmer Biomet Holdings Inc简介

公司代码ZBH
公司名称Zimmer Biomet Holdings Inc
上市日期Jul 25, 2001
CEOTornos (Ivan)
员工数量17000
证券类型Ordinary Share
年结日Jul 25
公司地址345 E Main St
城市WARSAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编46580-2746
电话15742676131
网址https://www.zimmerbiomet.com/en
公司代码ZBH
上市日期Jul 25, 2001
CEOTornos (Ivan)

Zimmer Biomet Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--
Mr. Syed A. Jafry
Mr. Syed A. Jafry
Independent Director
Independent Director
4.06K
--
Mr. Robert A. Hagemann
Mr. Robert A. Hagemann
Independent Director
Independent Director
4.00K
--
Mr. Paul A. Stellato
Mr. Paul A. Stellato
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
3.42K
+34.66%
Mr. Arthur J. (Art) Higgins
Mr. Arthur J. (Art) Higgins
Independent Director
Independent Director
3.40K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Chad F. Phipps
Mr. Chad F. Phipps
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
59.37K
+2.19%
Mr. Suketu P. Upadhyay
Mr. Suketu P. Upadhyay
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
54.75K
+12.08%
Mr. Ivan Tornos
Mr. Ivan Tornos
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
51.75K
+9.73%
Mr. Sang Yi
Mr. Sang Yi
Group President, Asia Pacific
Group President, Asia Pacific
18.42K
-6.11%
Ms. Lori Winkler
Ms. Lori Winkler
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
6.79K
--
Ms. Betsy J. Bernard
Ms. Betsy J. Bernard
Independent Director
Independent Director
5.27K
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%
地区USD
名称
营收
占比
United States
1.17B
56.51%
International
903.50M
43.49%
业务
地区
业务USD
名称
营收
占比
Knees
826.00M
39.76%
S E T
550.60M
26.51%
Hips
536.10M
25.81%
Other product category
164.60M
7.92%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
其他
59.19%
持股股东
持股股东
占比
Dodge & Cox
11.71%
The Vanguard Group, Inc.
11.70%
T. Rowe Price Associates, Inc.
7.46%
BlackRock Institutional Trust Company, N.A.
5.58%
State Street Investment Management (US)
4.36%
其他
59.19%
股东类型
持股股东
占比
Investment Advisor
54.12%
Investment Advisor/Hedge Fund
37.70%
Hedge Fund
2.18%
Pension Fund
2.06%
Research Firm
1.73%
Bank and Trust
1.28%
Sovereign Wealth Fund
1.27%
Individual Investor
0.13%
Family Office
0.07%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1945
195.45M
98.66%
-607.37K
2025Q2
1996
190.39M
96.22%
-5.04M
2025Q1
2047
189.51M
95.78%
-9.49M
2024Q4
2042
186.55M
93.71%
-18.21M
2024Q3
1986
185.93M
91.29%
-23.02M
2024Q2
1982
190.82M
92.76%
-16.12M
2024Q1
1974
190.22M
92.57%
-13.55M
2023Q4
1991
188.03M
89.99%
-18.28M
2023Q3
1984
188.24M
90.09%
-20.30M
2023Q2
2003
190.89M
91.52%
-16.92M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Dodge & Cox
22.10M
11.15%
+2.01M
+10.01%
Jun 30, 2025
The Vanguard Group, Inc.
23.16M
11.69%
+196.58K
+0.86%
Jun 30, 2025
T. Rowe Price Associates, Inc.
14.50M
7.32%
+336.36K
+2.37%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
10.93M
5.52%
-195.19K
-1.75%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.42%
-6.59K
-0.08%
Jun 30, 2025
Capital International Investors
6.77M
3.42%
+6.77M
--
Jun 30, 2025
Geode Capital Management, L.L.C.
5.12M
2.59%
+69.48K
+1.37%
Jun 30, 2025
American Century Investment Management, Inc.
5.71M
2.88%
+458.90K
+8.74%
Jun 30, 2025
Harris Associates L.P.
3.73M
1.88%
+3.73M
--
Jun 30, 2025
PRIMECAP Management Company
4.71M
2.38%
+27.86K
+0.59%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Langar Global HealthTech ETF
4.98%
VanEck Morningstar Wide Moat Value ETF
4.58%
Leatherback Long/Short Alternative Yield ETF
2.9%
VanEck Morningstar Wide Moat ETF
2.46%
iShares U.S. Medical Devices ETF
2.37%
First Trust Indxx Medical Devices ETF
2.13%
American Century Focused Large Cap Value ETF
2.03%
Invesco Raymond James SB-1 Equity ETF
1.87%
First Trust Health Care Alphadex Fund
1.78%
State Street SPDR S&P Health Care Equipment ETF
1.75%
查看更多
Langar Global HealthTech ETF
占比4.98%
VanEck Morningstar Wide Moat Value ETF
占比4.58%
Leatherback Long/Short Alternative Yield ETF
占比2.9%
VanEck Morningstar Wide Moat ETF
占比2.46%
iShares U.S. Medical Devices ETF
占比2.37%
First Trust Indxx Medical Devices ETF
占比2.13%
American Century Focused Large Cap Value ETF
占比2.03%
Invesco Raymond James SB-1 Equity ETF
占比1.87%
First Trust Health Care Alphadex Fund
占比1.78%
State Street SPDR S&P Health Care Equipment ETF
占比1.75%

分红派息

近5年累计派现 996.70M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Dec 17, 2025
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 30, 2026 going ex on Dec 30, 2025 with reinvestment option
Dec 30, 2025
Jan 30, 2026
Dec 30, 2025
Aug 27, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2025 going ex on Sep 30, 2025 with reinvestment option
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 30, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2025 going ex on Jun 26, 2025
Jun 26, 2025
Jul 31, 2025
Jun 26, 2025
Feb 26, 2025
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024 with reinvestment option
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Dec 18, 2024
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2025 going ex on Dec 30, 2024
Dec 30, 2024
Jan 31, 2025
Dec 30, 2024
Aug 29, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Oct 31, 2024 going ex on Sep 30, 2024 with reinvestment option
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 13, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Jul 31, 2024 going ex on Jun 26, 2024 with reinvestment option
Jun 26, 2024
Jul 31, 2024
Jun 26, 2024
Feb 21, 2024
ZBH.NB Interim Cash Dividend of gross USD 0.24 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 14, 2023
ZBH.NB Final Cash Dividend of gross USD 0.24 paid on Jan 31, 2024 going ex on Dec 26, 2023
Dec 27, 2023
Jan 31, 2024
Dec 26, 2023
查看更多

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Zimmer Biomet Holdings Inc的前五大股东是谁?

Zimmer Biomet Holdings Inc 的前五大股东如下:
Dodge & Cox持有股份:22.10M,占总股份比例:11.15%。
The Vanguard Group, Inc.持有股份:23.16M,占总股份比例:11.69%。
T. Rowe Price Associates, Inc.持有股份:14.50M,占总股份比例:7.32%。
BlackRock Institutional Trust Company, N.A.持有股份:10.93M,占总股份比例:5.52%。
State Street Investment Management (US)持有股份:8.75M,占总股份比例:4.42%。

Zimmer Biomet Holdings Inc的前三大股东类型是什么?

Zimmer Biomet Holdings Inc 的前三大股东类型分别是:
Dodge & Cox
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.

有多少机构持有Zimmer Biomet Holdings Inc(ZBH)的股份?

截至2025Q3,共有1945家机构持有Zimmer Biomet Holdings Inc的股份,合计持有的股份价值约为195.45M,占公司总股份的98.66%。与2025Q2相比,机构持股有所增加,增幅为2.44%。

哪个业务部门对Zimmer Biomet Holdings Inc的收入贡献最大?

在FY2025Q2,Knees业务部门对Zimmer Biomet Holdings Inc的收入贡献最大,创收826.00M,占总收入的39.76%。
KeyAI